PGP and in situ carcinoma: As P-gp transports many cytotoxic drugs, our next step was to assess the resistance of the investigated cell lines to PAC and DOX, a commonly used P-gp substrate and a cytotoxic drug that is not a substrate of this protein—CIS [18].